Item 7.01 and in Exhibits 99.1 and 99.2 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
 
Item 9.01 Financial Statements and Exhibits
 
99.1
Press Release of China Yongxin Pharmaceuticals Inc. dated June 18, 2008
99.2
Press Release of China Yongxin Pharmaceuticals Inc. dated June 30, 2008

 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   
China Yongxin Pharmaceuticals Inc.
 
     
Dated: July 1, 2008
  
        /s/ Ning Liu                                              
   
By:  Ning Liu
   
Its:President and Chief Operating Officer